Bristol Myers Squibb’s mavacamten delivers positive topline results from Phase III VALOR-HCM...
Category: Heart Failure
An innovative implant-free technology may help individuals with chronic heart failure. According...Read More
- FDA Approves First Therapy Specific for RET-Driven Lung and Thyroid Cancers
- The Plate Method for Managing Diabetes and Other Inflammatory Diseases
- Positive Topline Results for Patients with Heart Disease
- Great News for High-Risk Breast Cancer Patients
- FDA’s Expanded Indication Treats More People with Heart Failure